Emerging Nanotechnologies for Medical Applications 2023
DOI: 10.1016/b978-0-323-91182-5.00001-2
|View full text |Cite
|
Sign up to set email alerts
|

Nanoinformatics and nanomodeling: Recent developments in computational nanodrug design and delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 65 publications
0
4
0
Order By: Relevance
“…To address these challenges, efforts are underway to identify data gaps and prioritize research needs for specific nanomaterials and physicochemical properties. This includes efforts to develop and implement new experimental methods and protocols for collecting data on nanomaterials, as well as improving data sharing and collaboration across different sectors and regions …”
Section: Quantitative Structure–activity Relationship For Nanomateria...mentioning
confidence: 99%
See 1 more Smart Citation
“…To address these challenges, efforts are underway to identify data gaps and prioritize research needs for specific nanomaterials and physicochemical properties. This includes efforts to develop and implement new experimental methods and protocols for collecting data on nanomaterials, as well as improving data sharing and collaboration across different sectors and regions …”
Section: Quantitative Structure–activity Relationship For Nanomateria...mentioning
confidence: 99%
“…Nano-QSAR, or quantitative structure–activity relationship modeling to nanomaterials, represents a burgeoning research field focused on predicting the toxicological effects of nanomaterials on biological systems based on their physicochemical properties . This approach is especially pertinent in the context of nanomaterials used in agriculture, where direct contact with soil, plants, animals, and humans raises concerns about potential adverse health effects .…”
Section: Introductionmentioning
confidence: 99%
“…The reasons for this limited success are multifaceted. Firstly, the molecular diversity of lung cancer means that a single-target drug may only be effective for a subset of patients whose tumours harbour the specific target [ 11 , 12 , 13 , 14 , 15 ]. In essence, these drugs often fail to account for the heterogeneous nature of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…Ras and related G proteins are relied upon for more broad applications to different compounds that catalyze phosphoryl )-PO)3(2-(, including kinases and phosphatases. [13][14][15][16] To comprehend the molecular mechanisms of hidden bortezomib obstruction, we should recognize the potential objective genes differentially expressed in bortezomib-safe leukemia cells versus organ controls. [17][18][19][20] In this study, we extricate the short sequence repeats )SSRs( to comprehend this issue and focus on the medication component with new methodologies.…”
mentioning
confidence: 99%